Metraipolis › archive › dc_ccba5177fc3d
Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial — Europe PMC PMID:42318167
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42318167
- DOI
- 10.1016/j.lanepe.2026.101744
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T13:55:25.219Z
- SHA-256 of the archived text
7b9cfd330ce22705f23e18e87513df089f57045a94b901f5b41c27d44b7cf854- Stable URL of this page
https://metraipolis.com/documento/dc_ccba5177fc3d
How to cite
Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial — Europe PMC PMID:42318167 — Europe PMC (en), https://europepmc.org/article/MED/42318167 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccba5177fc3d (Metraipolis archive dc_ccba5177fc3d, sha256 7b9cfd330ce22705f23e18e87513df089f57045a94b901f5b41c27d44b7cf854)
BibTeX
@misc{dcccba5177fc3d,
title = {Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial — Europe PMC PMID:42318167},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42318167},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccba5177fc3d; sha256 7b9cfd330ce22705f23e18e87513df089f57045a94b901f5b41c27d44b7cf854},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42318167. Agents can read the archived copy with the MCP tool read_document.